Ingmar Gorman, Ph.D. clinical psychologist and principal investigator in MAPS’ research into MDMA-assisted psychotherapy, is our guest this week. Ingmar shares with us his journey into the world of psychedelic therapy, and what he hopes the research at MAPS can achieve. We also discuss the rise of microdosing, and why Ingmar believes we should be cautious about its benefits.
For show links: https://thethirdwave.co/podcast/episode-47-ingmar-gorman/
Sign up to our microdosing course! https://thethirdwave.co/microdosing-course/
